Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Limbix Spark: A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19

NCT04524598 is registered in ClinicalTrials.gov with Limbix Health, Inc. as lead sponsor.

NCT NCT04524598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04524598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Limbix Spark: A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19
Lead sponsor
Limbix Health, Inc.
Phase
Not applicable
Overall status
Completed
Start date
July 20, 2020
Completion date
January 16, 2022
Enrollment
227 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression